YOU OR a fellow scientist have discovered a new gene. Amidst the furious paper and grant writing that follows, someone wonders, " Can we get a patent for this?" Everyone stares blankly, then goes back to work. You realize 10 years later that you lost out on millions of dollars of profits from the invention.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.